Erratum: XBP1S Regulates MUC5B in a Promoter Variant–Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia | Zendy

Hyun-Woo Choi | Zendy; Ju-Hyeon Shin | Zendy; SeungJung Kee | Zendy; Yong Soo Kwon | Zendy; Hyunseung Lee | Zendy; Jeong Eun | Zendy; Jong Hee Shin | Zendy

Open Access

Erratum: XBP1S Regulates MUC5B in a Promoter Variant–Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia

Author(s) -

Hyun-Woo Choi,

Ju-Hyeon Shin,

SeungJung Kee,

Yong Soo Kwon,

Hyunseung Lee,

Jeong Eun,

Jong Hee Shin

Publication year - 2019

Publication title -

american journal of respiratory and critical care medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.272

H-Index - 374

eISSN - 1535-4970

pISSN - 1073-449X

DOI - 10.1164/rccm.v200erratum6

Subject(s) - medicine , idiopathic pulmonary fibrosis , airway , pulmonary fibrosis , fibrosis , pathology , lung , surgery

1. Lee HS, Kee SJ, Shin JH, Kwon YS, Chun S, Lee JH, et al. Xpert MTB/RIF assay as a substitute for smear microscopy in an intermediate-burden setting. Am J Respir Crit Care Med 2019;199: 784–794. 2. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175: 367–416. [Published erratum appears in Am J Respir Crit Care Med 175:744–745.] 3. Kwon YS, Koh WJ, Daley CL. Treatment of Mycobacterium avium complex pulmonary disease. Tuberc Respir Dis (Seoul) 2019;82:15–26. 4. Philley JV, DeGroote MA, Honda JR, Chan MM, Kasperbauer S, Walter ND, et al. Treatment of non-tuberculous mycobacterial lung disease. Curr Treat Options Infect Dis 2016;8:275–296. 5. Friedrich SO, Rachow A, Saathoff E, Singh K, Mangu CD, Dawson R, et al.; Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics (PanACEA). Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. Lancet Respir Med 2013;1:462–470. 6. Sali M, De Maio F, Caccuri F, Campilongo F, Sanguinetti M, Fiorentini S, et al. Multicenter evaluation of Anyplex Plus MTB/NTM MDRTB assay for rapid detection of Mycobacterium tuberculosis complex and multidrug-resistant isolates in pulmonary and extrapulmonary specimens. J Clin Microbiol 2016;54:59–63.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research